Stocks and InvestingStocks and Investing
Mon, February 26, 2024
Fri, February 23, 2024

Caitlin Cronin Reiterated (ZBH) at Hold and Held Target at $130 on, Feb 23rd, 2024


Published on 2024-10-28 09:11:08 - WOPRAI, Caitlin Cronin
  Print publication without navigation


Caitlin Cronin of Canaccord Genuity, Reiterated "Zimmer Biomet Holdings, Inc." (ZBH) at Hold and Held Target at $130 on, Feb 23rd, 2024.

Caitlin has made no other calls on ZBH in the last 4 months.



There are 8 other peers that have a rating on ZBH. Out of the 8 peers that are also analyzing ZBH, 4 agree with Caitlin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Richard Newitter of "Truist Securities" Maintained at Hold with Increased Target to $135 on, Friday, February 9th, 2024
  • Robbie Marcus of "JP Morgan" Maintained at Hold with Increased Target to $125 on, Friday, February 9th, 2024
  • Vijay Kumar of "Evercore ISI Group" Downgraded from Buy to Hold and Decreased Target to $125 on, Thursday, January 4th, 2024
  • Cecilia Furlong of "Morgan Stanley" Maintained at Hold with Increased Target to $125 on, Monday, December 4th, 2023


These are the ratings of the 4 analyists that currently disagree with Caitlin


  • Matt Miksic of "Barclays" Maintained at Sell with Increased Target to $130 on, Monday, February 12th, 2024
  • Shagun Singh of "RBC Capital" Reiterated at Buy and Held Target at $140 on, Friday, February 9th, 2024
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $137 on, Wednesday, January 3rd, 2024
  • David Turkaly of "JMP Securities" Maintained at Buy with Decreased Target to $140 on, Monday, November 13th, 2023